Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-administration of FGF-21 and GLP-1 to treat diabetes and lower blood glucose

Co-administration of FGF-21 and GLP-1 to treat diabetes and lower blood glucose

US Patent 8557769 · Granted Oct 15, 2013

Estimated economic value: $211,789,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using and compositions including an incretin analog2025
Method of using a GIP/GLP1 co-agonist for diabetes2025
Incretin analogs and uses thereof2025
Model based dynamic positional correction for digital lithography tools2025
Incretin analogs and uses thereof2025
Deep learning based adaptive alignment precision metrology for digital overlay2025
Incretin analogs and uses thereof2025
Method of using a GIP/GLP1 co-agonist for diabetes2025
Universal metrology file, protocol, and process for maskless lithography systems2025
Overlaying on locally dispositioned patterns by ML based dynamic digital correct2025
Overlaying on locally dispositioned patterns by ML based dynamic digital correct2024
Incretin analogs and uses thereof2023